Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus

References

• Azam A, Eisenbarth GS. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes. Expert Opin Biol Ther 2004; 10: 1569–1579
   Google Scholar
• Gepts W, De Mey J. Islet cell survival determined by morphology. An immunocytochemical study of the islets of langerhans in juvenile diabetes mellitus. Diabetes 1978; 27(Suppl 1)257–261
   Google Scholar
• DeBaets MD. Autoimmune endocrine diseases. Year Immunol 1989; 4: 264–275
   PubMedGoogle Scholar
• Doberson MD, Scharff JE, Ginsberg-Fellner F, Notkins AL. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 1980; 303: 1493–1498
   PubMedGoogle Scholar
• Bottazzo GF, Florin-Christensen AF, Donaich D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279–1282
   PubMed Web of Science ®Google Scholar
• Jackson RA, Morris MA, Haynes BF, Eisenbarth GS. Increased circulating Ia antigen-bearing T cells in type 1 diabetes mellitus. N Engl Med 1984; 306: 785–788
   Google Scholar
• Al-Kassab AS, Raziuddin S. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type 1 diabetes mellitus. Clin Exp Immunol 1990; 81: 267–271
   PubMedGoogle Scholar
• Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Herold KC, Lanki DW, Moldwin RL, Fitch FW. Immunosuppressive effects of cyclosporin A on cloned T cells. J Immunol 1986; 136: 1315–1321
   PubMedGoogle Scholar
• Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL, Bach JF. Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl Med 1988; 318: 663–670
   PubMed Web of Science ®Google Scholar
• Bierworf B, Verlohren HJ, Lohmann D, Lampeter EF, Krug J. A follow-up study of cell mediated cytotoxicity and beta cell function in type 1 diabetes. Exp Clin Endocrinol 1987; 89: 363–367
   PubMedGoogle Scholar
• Lohmann T, Leslie RDG, Londei M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmun 1996; 385–389
   PubMedGoogle Scholar
• Tabata H, Kanai T, Yoshizumi H, Nishiyama S, Fujimoto S, Matsuda I, Yasukawa M, Matsushita S, Nishimura Y. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus. Hum Immunol 1998; 59: 549–560
   PubMed Web of Science ®Google Scholar
• Schloot NC, Willemen SJM, Duinkerken SG, de Vries RRP, Roep BO. Clones T cells from a recent onset T1D patient reactive with insulin B-chain. J Autoimmun 1998; 11: 169–175
   PubMed Web of Science ®Google Scholar
• Yuriko I, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, Obata F, Tadokoro K, Hirata Y, Omori Y, Juji T. Recognition of human insulin in the context of HLA-DRB1*406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 1993; 151: 5770–5776
   PubMedGoogle Scholar
• Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, Christie MR, Roep BO. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 2000; 49(3)356–366
   PubMed Web of Science ®Google Scholar
• Kallan AR, Duinkerken G, de Jong R, van den Elsen P, Hutton JC, Martin S, Roep BO, de Vries RRP. Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T-cells from newly diagnosed type 1 diabetes patients after stimulation with β-cell antigens. J Autoimmun 1997; 10: 589–598
   PubMedGoogle Scholar
• Sobel DO, Fleisher T, Karounos DG. Characterization of a human T cell line reactive to a 52 kDa islet protein. J Autoimmun 1997; 10: 387–394
   PubMedGoogle Scholar
• Elias D, Meilin A, Ablamonits V, Birk OS, Carmi P, Konen-Waisman S, Cohen IR. Hsp60 peptide therapy of NOD mouse diabetes induced a Th2 cytokine burst and down-regulates autoimmunity to various β-cell antigens. Diabetes 1997; 46: 758–764
   PubMed Web of Science ®Google Scholar
• Elias D, Cohen IR. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995; 44: 1132–1138
   PubMed Web of Science ®Google Scholar
• Kallan AA, Roep BO, Arden SD, Hutton JC, de Vries RRP. Beta-cell reactive T-cell clones from type I diabetes patients are not beta cell specific and recognize multiple antigens. J Autoimmun 1995; 8: 887–899
   PubMedGoogle Scholar
• Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, de Vries GRRP, Hutton JC. Imogen 38, a novel 38-kD islet mitochondrial autoantigen recognized by T cells from newly diagnosed type 1 diabetic patients. J Clin Invest 1996; 97: 551–561
   PubMed Web of Science ®Google Scholar
• Lacy PE, Kostianovsky M. Method for the isolation of intact islets of langerhans from the rat pancreas. Diabetes 1967; 16: 35–39
   PubMed Web of Science ®Google Scholar
• Lamb JR, Eckels DD, Lake P, Johnson AH, Hartzman RJ, Woody JN. Antigen specific human T lymphocyte clones: Induction antigen specificity, and MHC restriction of influenza virus immune clones. J Immunol 1982; 128: 233–238
   PubMedGoogle Scholar
• Lampson LA, Levy R. Two populations of Ia-like molecules in a human B cell line. J Immunol 1980; 125: 293–299
   PubMedGoogle Scholar
• Richert JR, Robinson ED, Deibler GE, Martenson RE, Grajovic LJ, Kies MW. Human cytolytic T-cell recognition of a synthetic peptide of myelin based protein. Ann Neurol 1989; 26: 342–346
   PubMedGoogle Scholar
• Robbins PA, Evans EL, Ding AH, Warner NL, Brodsky FM. Monoclonal antibodies that distinguish between Class II antigens (HLA-DP, DQ and DR) in 14 haplotypes. Hum Immunol 1987; 18: 301–313
   PubMedGoogle Scholar
• Radka SF, Stewart SJ, Smith SA. Analysis of HLA-DQ molecules with a monoclonal antibody detecting a DQ polymorphism absent from DQW1 homozygous cells. Hum Immunol 1984; 14: 206–219
   Google Scholar
• Selmaj K, Brosnan CF, Raine CS. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA 1991; 88: 6452–6456
   PubMed Web of Science ®Google Scholar
• Res PC, Schaar CG, Breedveld FC, Van Eden W, Van Embden JD, Cohen IR, De Vries RRP. Synovial fluid T-cell reactivity against 65-kDa heat shock in protein of mycobacteria in early chronic arthritis. Lancet ii 1988; 478–480
   PubMedGoogle Scholar
• De Graeff-Meeder ER, Van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, Zegers BJ, Van Eden W. Recognition of human 60 kDa heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991; 337: 1368–1372
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Cohen IR. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol 2002; 169: 6030
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Holmes LA, Scharp DW, Lacy PE, Maclaren NK. No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes. J Clin Invest 1991; 87: 721–724
   PubMedGoogle Scholar
• Ozawa Y, Kasuga A, Nomaguchi H, Maruyama T, Kasatani T, Shimada A, Takei I, Miyazaki J, Saruta T. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus. J Autoimmun 1996; 9: 517–524
   PubMed Web of Science ®Google Scholar
• Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H, Cohen IR. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 1999; 12: 121–129
   PubMed Web of Science ®Google Scholar
• Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen I. β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): A randomized, double-blind phase II trial. Lancet 2001; 358: 1749–1753
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS, Jasinski JM. Disease prevention with islet autoantiigens. Endocrinol Metab Clin 2004; 33: 1–13
   Google Scholar
• Cechetto JD, Soltys BJ, Gupta RS. Localization of mitochrondrial 60-kD heat shock chaperonin protein (Hsp60) in pituitary growth hormone secretory granules and pancreatic zymogen granules. J Histochem Cytochem 2000; 48(1)45–56
   PubMedGoogle Scholar
• Pearse AGE, Takor-Takor T. Embryology of the diffuse neuroendocrine system and its relationship to the common peptides. Fed Proc 1979; 38: 2288–2294
   PubMedGoogle Scholar
• Cohen LR. The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes. Clin Immunol Immunopathol 1977; 84: 103–106
   Google Scholar
• Karounos DG, Thomas JW. Recognition of a common islet-cell antigen by autoantibodies from NOD mice and humans with T1D. Diabetes 1990; 39: 1085–1090
   PubMed Web of Science ®Google Scholar
• Karounos DG, Nell LJ, Thomas JW. Autoantibodies present at onset of type 1 diabetes recognize multiple islet cell antigens. Autoimmunity 1990; 6: 79–91
   PubMed Web of Science ®Google Scholar
• Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, DeVries RRP. Human T-cell clones with specificity for insulinoma cell antigens. Eur J Immunol 1989; 19: 213–216
   PubMed Web of Science ®Google Scholar
• Durinovic-Bello I, Steinle A, Zielger AG, Schendel DJ. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient. Diabetes 1994; 1318–1325
   PubMedGoogle Scholar
• Schloot NC, Willemen SJM, Duinkerken G, Drijfhout JW, de Vries RRP, Roep BO. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to coxsackie or proinsulin peptides do not cross-react with homologous counterpart. Hum Immunol 2001; 62: 299–309
   PubMedGoogle Scholar
• Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol 2003; 56: 1–10
   PubMedGoogle Scholar
• Haanen JBAG, de Waal Malefijt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991; 91: 583–591
   Google Scholar
• Russo DM, Chakrabarti P, Burns JM, Jr. Naïve human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages. J Infect Dis 1998; 177(5)1345–1351
   PubMedGoogle Scholar
• Geluk A, van Meijgaarden KE, Roep BO, Ottenhoff THM. Altered peptide ligands of islet autoantigen imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes. J Autoimmun 1998; 11: 353–361
   PubMed Web of Science ®Google Scholar
• Swain SL. T cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129–142
   PubMed Web of Science ®Google Scholar
• Foulis AK, Farquharson MA, Hardman R. Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 333–343
   PubMed Web of Science ®Google Scholar
• Horvath MD, Varsanyi Schroder M, Balazsi I. Human pancreatic extract and rat pancreatic islet homogenate-coated chicken erythrocytes as targets of lymphocyte-mediated cytotoxicity in type I diabetic patients. Exp Clin Endocrinol 1989; 93: 151–156
   PubMedGoogle Scholar
• Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes 1996; 45: 1299–1305
   PubMed Web of Science ®Google Scholar
• De Berardinis P, James RFL, Wise PH, Londei M, Lake SP, Feldmann M. Do CD4-positive cytotoxic T cells damage islet β cells in type 1 diabetes. Lacent 1988; 823–824
   Google Scholar
• Roep BO, Kallan AA, DeVries RRP. β-cell antigen—specific lysis of macrophages by CD4 T-cell clones from newly diagnosed T1D patient: A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes 1992; 41: 1380–1384
   PubMedGoogle Scholar
• Roep BO, Arden SD, deVries RRP, Hutton JC. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Lett Nat 1990; 345: 632–634
   PubMed Web of Science ®Google Scholar